Get started
Author

Katrin Birkholz

Observed names: Birkholz, K., Birkholz, Katrin Martina 1980-, K Birkholz, K. Birkholz
ORCID: 0000-0001-9637-4709
Observed ORCID: 0000-0001-9637-4709
OpenAlex ID: A5077588177
Targeting of DEC-205 on human dendritic cells results in efficient MHC class II–restricted antigen presentation
2010 · Katrin Birkholz, Michael Schwenkert, et al. · Blood · 146
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer
2009 · K Birkholz, A Hombach, et al. · Gene Therapy · 116
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone
2015 · Christian Krug, Katrin Birkholz, et al. · Cancer Immunology Immunotherapy · 55
Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study
2014 · P. Hadji, A. Kauka, et al. · Osteoporosis International · 30
A fast and robust method to clone and functionally validate T-cell receptors
2009 · Katrin Birkholz, Christian Hofmann, et al. · Journal of Immunological Methods · 30
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells
2008 · Michael Schwenkert, Katrin Birkholz, et al. · Melanoma Research · 21
Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
2014 · M. Vogelhuber, S. Feyerabend, et al. · Cancer Microenvironment · 15
PDF
Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study
2014 · Peyman Hadji, Annette Kauka, et al. · Breast Cancer Research and Treatment · 12
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
2012 · Ulf W Tunn, Amulf Stenzl, et al. · PubMed · 12
A phase II study of imatinib with pioglitazone, etoricoxib, dexamethasone, and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory, and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC).
2011 · A. Reichle, M. Vogelhuber, et al. · Journal of Clinical Oncology · 10
The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence‐Based Approach
2025 · Oliver Pfaar, Ralph Mösges, et al. · Allergy · 7
PDF
Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season
2019 · Ralph Mösges, Nils Y. Breitrück, et al. · World Allergy Organization Journal · 6
PDF
The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer
2012 · Peyman Hadji, May Ziller, et al. · Journal of bone oncology · 3
PDF
Dendritic cell vaccination and other strategies to tip the balance of the immune system: DC2007 5th international meeting, July 16–18, Bamberg, Germany
2008 · Niels Schaft, Katrin Birkholz, et al. · Cancer Immunology Immunotherapy · 3
PDF
Dendritic cell vaccination and other strategies to tip the balance of the immune system: DC2007 5th international meeting, July 16–18, Bamberg, Germany
2008 · Niels Schaft, Katrin Birkholz, et al. · Cancer Immunology Immunotherapy · 3
TAPAS—A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis—Design and Early Results
2025 · Michael Gerstlauer, Julia Hiller, et al. · Journal of Clinical Medicine · 2
PDF
Clinical performance of house-dust-mite-specific subcutaneous immunotherapy in a postmarket noninterventional setting
2020 · Petra Zieglmayer, Ralph Mösges, et al. · Allergo Journal International · 2
PDF
P2-19-03: Influence of Zoledronic Acid on BMD in Premenopausal Women with Breast Cancer and Neoadjuvant or Adjuvant Chemotherapy and/or Endocrine Treatment – The ProBone Studies.
2011 · P Hadji, A Kauka, et al. · Cancer Research · 1
The ZOTECT study: Effect of intravenous zoledronic acid on bone metabolism in patients with metastatic bone disease in prostate cancer (PC) and breast cancer (BC).
2011 · P. Hadji, M. Ziller, et al. · Journal of Clinical Oncology · 1
Short-Course Allergen-Specific Immunotherapy with Modified Grass/Tree Allergoids Using a Microcrystalline Tyrosine (MCT®) and Monophosphoryl Lipid A (MPL) Adjuvant System Decreases Specific Immunoglobulin E Levels
2022 · Practice for Pulmonary and Bronchial Medicine, Cologne, Germany, Dietrich Stollewerk, et al. · European Journal of Rhinology and Allergy
Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
2015 · M. Vogelhuber, S. Feyerabend, et al. · Cancer Microenvironment
PDF
Eine randomisierte, unverblindete, neoadjuvante Phase-II-Studie mit einer wöchentlichen Gabe von Paclitaxel mit oder ohne LCL161, einem oralen IAP- Antagonisten (inhibitor of proteins, IAP), bei Patientinnen mit Triple-negativem Brustkrebs (TNBC)
2013 · C Liedtke, R Dienstmann, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Effects of zoledronic acid on hormone levels in premenopausal women with breast cancer receiving neoadjuvant or adjuvant chemotherapy and endocrine therapy: Probone II Study
2013 · Peyman Hadji, Anette Kauka, et al. · Bone Abstracts
Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer: the ZOTECT Study
2013 · Peyman Hadji, May Ziller, et al. · Bone Abstracts
Effect of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for breast cancer: the ProBONE II Study
2013 · Peyman Hadji, Anette Kauka, et al. · Bone Abstracts
Works count: 33
Citation count: 475
H-index: 10
I10-index: 10
Year
Topic
Type